Idenix Pharmaceuticals to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
CAMBRIDGE, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (IDIX) announced today that Idenix management will present a corporate overview at the 2012 Wedbush PacGrow Lifesciences Management Access Conference on Wednesday, August 15, 2012 at 8:35 a.m. ET at the Le Parker Meridien hotel, New York City.
The live and archived webcast of the company presentation can be accessed under "Events & Presentations" in the Idenix Investor Center at www.idenix.com . Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com .
CONTACT: Idenix Pharmaceuticals Contact: Kelly Barry (617) 995-9033 (media) Daniella Beckman (617) 995-4471 (investors)Source: Idenix Pharmaceuticals 2012 GlobeNewswire, Inc.